Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia

Infectious Diseases

Volumn 48, Issue 10, 2016, Pages 732-737

  MacVane, Shawn H ^a   Hurst, John M ^a   Boger, M Sean ^a   Gnann, John W ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bacteremia; Enterococcus; outcomes; rapid diagnostics

Indexed keywords

DAPTOMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACHROMOBACTER XYLOSOXIDANS; ACINETOBACTER BAUMANNII; ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACILLUS; BACTEREMIA; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CHRYSEOBACTERIUM; CONTROLLED STUDY; COST OF ILLNESS; ENTEROCOCCAL INFECTION; ESCHERICHIA COLI; FEMALE; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY TEST; MORTALITY; MULTIPLEX POLYMERASE CHAIN REACTION; OUTCOME ASSESSMENT; PICHIA KUDRIAVZEVII; POLYMERASE CHAIN REACTION SYSTEM; PSEUDOMONAS AERUGINOSA; QUASI EXPERIMENTAL STUDY; RAPID TEST; SPHINGOMONAS; STENOTROPHOMONAS MALTOPHILIA; VANCOMYCIN RESISTANT ENTEROCOCCUS; ADOLESCENT; AGED; CONTROLLED CLINICAL TRIAL (TOPIC); GENETICS; GRAM-POSITIVE BACTERIAL INFECTIONS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD CULTURE; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; NON-RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME; VANCOMYCIN-RESISTANT ENTEROCOCCI; YOUNG ADULT;

EID: 84978529230     PISSN: 23744235     EISSN: None     Source Type: Journal    
DOI: 10.1080/23744235.2016.1185533     Document Type: Article

References (14)

1. D.M.Sievert, P.Ricks, J.R.Edwards,.; National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34:1–14.
2. A.M.Ramsey, M.D.Zilberberg Secular trends of hospitalization with vancomycin-resistant Enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol. 2009;30:184–186.
3. C.A.DiazGranados, S.M.Zimmer, M.Klein,. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41:327–333.
4. K.A.Bauer, K.K.Perez, G.N.Forrest,. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis. 2014;59:S134–S145.
5. A.J.Blaschke, C.Heyrend, C.L.Byington,. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis. 2012;74:349–355.
6. P.A.Harris, R.Taylor, R.Thielke,. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–381.
7. T.H.Dellit, R.C.Owens, J.E.McGowan, Jr,. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–177.
8. M.Tumbarello, T.Spanu, R.Di Bidino,. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010;54:4085–4091.
9. L.Leibovici, I.Shraga, M.Drucker,. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998;244:379–386.
10. A.Sango, Y.S.McCarter, D.Johnson,. Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species. J Clin Microbiol. 2013;51:4008–4011.
11. D.G.Roshdy, A.Tran, N.LeCroy,. Impact of a rapid microarray-based assay for identification of positive blood cultures for treatment optimization for patients with streptococcal and enterococcal bacteremia. J Clin Microbiol. 2015;53:1411–1414.
12. M.J.Box, E.L.Sullivan, K.N.Ortwine,. Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system. Pharmacotherapy. 2015;35:269–276.
13. S.G.Beal, C.Thomas, N.Dhiman,. Antibiotic utilization improvement with the nanosphere verigene gram-positive blood culture assay. Proc (Bayl Univ Med Cent). 2015;28:139–143.
14. A.L.Cheah, T.Spelman, T.Peel,. Impact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stay. Epidemiol Infect. 2014;142:2667–2671.